|
(Rac)-BAY1238097
|
(RAC)-BAY1238097
|
1564268-19-4
|
|
GSK1379725A
|
1802251-00-8
|
1802251-00-8
|
|
Sirt2-IN-1
|
SIRT2-IN-1
|
1862238-00-3
|
|
HJB97
|
|
2093391-24-1
|
|
INCB054329
|
1628607-64-6
|
1628607-64-6
|
|
CF53
|
CF53
|
1808160-52-2
|
|
TCS 21311
|
TCS21311; TCS-21311
|
1260181-14-3
|
|
GNE-049
|
化合物 T15397
|
1936421-41-8
|
|
DCP-LA
|
DCP-LA
|
28399-31-7
|
|
DCPLA-ME
|
DCPLA-ME
|
56687-67-3
|
|
EB-47 dihydrochloride
|
EB47; EB-47
|
1190332-25-2
|
|
BYK204165
|
4-((1-甲基-1H-吡咯-2-基)亞甲基)異喹啉-1,3(2H,4H)-二酮
|
1104546-89-5
|
|
GNE-781
|
GNE-781
|
1936422-33-1
|
|
GeA-69
|
N-(2-(9H-咔唑-1-基)苯基)乙酰胺
|
2143475-98-1
|
|
JFD00244
|
JFD00244
|
96969-83-4
|
|
Valemetostat tosylate
|
VALEMETOSTAT TOSYLATE
|
1809336-93-3
|
|
UNC0224
|
UNC 0224
|
1197196-48-7
|
|
UNC0321
|
UNC0321
|
1238673-32-9
|
|
EZM 2302
|
GSK 3359088
|
1628830-21-6
|
|
E-7386
|
E-7386
|
1799824-08-0
|
|
EBI-2511
|
化合物EBI-2511
|
2098546-05-3
|
|
CBP/EP300-IN-1
|
Benzoic acid, 3-[[(1-acetyl-5-methoxy-1H-indol-3-yl)carbonyl]amino]-4-fluoro-, 1,1-dimethylethyl ester
|
2443789-32-8
|
|
Y06036
|
Y06036
|
1832671-96-1
|
|
Y06137
|
Y06137
|
2226534-49-0
|
|
EHMT2-IN-2
|
EHMT2-IN-2
|
2230850-47-0
|
|
BRD7-IN-1
|
化合物BRD7-IN-1
|
2448414-48-8
|
|
MT1
|
MT1 BET INHIBITOR
|
2060573-82-0
|
|
ZL0420
|
ZL0420
|
2230496-80-5
|
|
NCGC00247743
|
1435192-04-3
|
1435192-04-3
|
|
BAY1238097
|
BAY1238097
|
1564268-08-1
|
|
(R)-BAY1238097
|
(R)-BAY1238097
|
1564269-85-7
|
|
BET bromodomain inhibitor
|
化合物BET BROMODOMAIN INHIBITOR
|
1505453-59-7
|
|
CMPD101
|
CMPD101
|
865608-11-3
|
|
T-3775440 hydrochloride
|
T-3775440鹽酸鹽
|
1422535-52-1
|
|
Fasudil Hydrochloride
|
鹽酸法舒地爾
|
105628-07-7
|
|
PROTAC Sirt2 Degrader-1
|
2MG
|
2098487-75-1
|
|
PF-06726304
|
PF-06726304
|
1616287-82-1
|
|
Seclidemstat
|
SECLIDEMSTAT
|
1423715-37-0
|
|
GSK2807 Trifluoroacetate
|
GSK2807 Trifluoroacetate
|
2245255-66-5
|
|
QC6352
|
QC6352
|
1851373-36-8
|
|
CAY10602
|
1-(4-氟苯基)-3-(苯磺?；?-1H-吡咯并[2,3-B]喹喔啉-2-胺
|
374922-43-7
|
|
SRT 1720
|
N-[2-[3-(1-哌嗪基甲基)咪唑并[2,1-B]噻唑-6-基]苯基]-2-喹喔啉甲酰胺
|
925434-55-5
|
|
Niraparib hydrochloride
|
MK-4827
|
1038915-64-8
|
|
Niraparib (R-enantiomer)
|
MK-4827 (R-enantioMer)
|
1038915-58-0
|
|
Delcasertib
|
Delcasertib
|
949100-39-4
|
|
SB-218078
|
SB218078
|
135897-06-2
|
|
BAY-299
|
BAY-299
|
2080306-23-4
|
|
GSK8573
|
GSK8573
|
1693766-04-9
|
|
R 59-022
|
化合物 T16709
|
93076-89-2
|
|
Bisindolylmaleimide X hydrochloride
|
BISINDOLYLMALEIMIDE X HYDROCHLORIDE (BIM-X HYDROCHLORIDE)
|
145317-11-9
|
|
SIRT5 inhibitor 1
|
2166487-21-2
|
2166487-21-2
|
|
PKC-theta inhibitor
|
MDK-8650
|
736048-65-0
|
|
SGC-iMLLT
|
SGC-IMLLT
|
2255338-25-9
|
|
Nudifloramide
|
1-甲基-6-氧代吡啶-3-甲酰胺
|
701-44-0
|
|
BI-9321 trihydrochloride
|
BI-9321 trihydrochloride
|
2387510-87-2
|
|
MRK-740
|
化合物 MRK-740
|
2387510-80-5
|
|
UBCS039
|
UBCS039
|
358721-70-7
|
|
PIN1 inhibitor API-1
|
O6-[4-(TRIFLUOROACETAMIDOMETHYL)BENZYL]GUANINE
|
680622-70-2
|
|
GSK467
|
化合物GSK467
|
1628332-52-4
|
|
(S)-JQ-35
|
1349719-98-7
|
1349719-98-7
|
|
BJE6-106
|
BJE6-106
|
1564249-38-2
|
|
PARP14 inhibitor H10
|
PARP14 INHIBITOR H10
|
2084811-68-5
|
|
MS402
|
MS-402
|
1672684-68-2
|
|
GNE-207
|
化合物 T15399
|
2158266-58-9
|
|
CMP-5
|
1-(9-ethyl-9H-carbazol-3-yl)-N-(pyridin-2-ylmethyl)methanamine
|
880813-42-3
|
|
KDM5-C70
|
ethyl 2-(((2-((2-(dimethylamino)ethyl)(ethyl)amino)-2-oxoethyl)amino)methyl)isonicotinate
|
1596348-32-1
|
|
MM-102 TFA
|
1883545-52-5
|
1883545-52-5
|
|
T-448
|
T-448
|
1597426-53-3
|
|
Nicotinamide riboside chloride
|
煙酰胺核苷
|
23111-00-4
|
|
(-)-Indolactam V
|
吲哚內(nèi)酰胺 V
|
90365-57-4
|
|
UNC0379 TFA
|
UNC-0379 TRIFLUOROACETATE
|
1620401-83-3
|
|
TPPB
|
TPPB
|
497259-23-1
|
|
LIN28 inhibitor LI71
|
LIN28 INHIBITOR LI71
|
1357248-83-9
|
|
ζ-Stat
|
8-羥基-1,3,6-萘三磺酸
|
3316-02-7
|
|
ζ-Stat trisodium
|
8-羥基-1,3,6-萘三磺酸三鈉鹽
|
31894-34-5
|
|
GNA002
|
GNA002
|
1385035-79-9
|
|
A-395
|
化合物A-395
|
2089148-72-9
|
|
JNJ-64619178
|
CS-2829
|
2086772-26-9
|
|
IACS-9571 hydrochloride
|
IACS-9571 hydrochloride
|
2319611-93-1
|
|
MOZ-IN-2
|
MOZ-IN-2
|
2055397-88-9
|
|
HA-100
|
1-(5-異喹啉磺?；?哌嗪鹽酸鹽
|
84468-24-6
|
|
GSK 4027
|
化合物 T11495L
|
2079896-25-4
|
|
GSK4028
|
2079886-19-2
|
2079886-19-2
|
|
D-erythro-Sphingosine
|
D-鞘氨醇
|
123-78-4
|
|
PBIT
|
2 - (4 - Methylphenyl) - 1,2 - benzisothiazol - 3(2H)-one
|
2514-30-9
|
|
AK-1
|
SIRT2 Inhibitor II, AK-1
|
330461-64-8
|
|
p32 Inhibitor M36
|
P32 INHIBITOR M36 (M36)
|
802555-85-7
|
|
CTPB
|
CTPB
|
586976-24-1
|
|
SRT 1460
|
3,4,5-三甲氧基-N-(2-(3-(哌嗪-1-基甲基)咪唑并[2,1-B]噻唑-6-基)苯基)苯甲酰胺
|
925432-73-1
|
|
DS-437
|
DS-437
|
1674364-87-4
|
|
BET-BAY 002
|
1588521-78-1
|
1588521-78-1
|
|
Cl-amidine hydrochloride
|
N-[(1S)-1-(氨基羰基)-4 -[(2 - 氯-1-亞氨基乙基氨基]丁基]-苯甲酰胺鹽酸鹽
|
1373232-26-8
|
|
Hispidin
|
6-[(1E)-2-(3,4-二羥基苯基)乙烯基]-4-羥基-2H-吡喃-2-酮
|
555-55-5
|
|
AZD5153 6-Hydroxy-2-naphthoic acid
|
AZD5153結(jié)晶體(API形式)
|
1869912-40-2
|
|
Lin28-let-7a antagonist 1
|
Lin28-IN-1
|
2024548-03-4
|
|
TPOP146
|
2018300-62-2
|
2018300-62-2
|
|
GNE-272
|
1936428-93-1
|
1936428-93-1
|
|
GSK9311
|
1923851-49-3
|
1923851-49-3
|
|
Histone Acetyltransferase Inhibitor II
|
組蛋白乙酰轉(zhuǎn)移酶 抑制劑II
|
932749-62-7
|
|
MS645
|
MS645
|
2250091-96-2
|